They are designed to act like one of these hormones, known as glucagon-like peptide 1 (GLP-1). The use of Mounjaro, also known as tirzepatide, was recorded as a contributing factor on Susan’s death certificate which lists multiple organ failure ...

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists, which are being rolled out on the NHS

Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to be effective for weight loss. It has been recommended as a weight loss drug for adults, with proposals for the phased launch of it on the NHS being set out by NICE.

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.

A nurse’s death has been linked to a weight loss drug which is approved for use on the NHS. Susan McGowan, 58, died on September 4 and had recently taken two doses of the weight loss jab Mounjaro. The drug,

The death of a Scots nurse has been linked to an approved weight loss injection which is available on NHS. Susan McGowan, from North Lanarkshire, took two low-dose injections of tirzepatide, known under the brand name Mounjaro,

Susan McGowan, 58, (pictured) from Lanarkshire, died after taking two low-dose injections of tirzepatide, known under the brand name Mounjaro.